Welcome : Guest

Endo International Plc (Ireland) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Endo International Plc, which is principally involved in Specialty Pharmaceuticals Business. Illustrated with 106 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-01915
Price: $3500
Company Type: Public
Pages: 113
Date: November 2016
Market Data Tables: 106

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Endo International Plc’s (U.S. Branded Pharmaceuticals) Sales by Product Segment Worldwide (2015) in Percentage for Pain Management (Lidoderm, Oana ER, Percocet, and Voltaren Gel), Specialty Pharmaceuticals (Supprelin LA & XiaflesxI), Urology (Fortesta Gel, including Authorized Generic & Testim, including Authorized Generic), and Branded Other Revenues......6
Table 2: Endo International Plc’s Sales by Business Segment Worldwide (2014-2015) in Percentage for U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, and International Pharmaceuticals......7
Table 3: Endo International Plc’s Sales by Business Segment Worldwide (2014) in Percentage for U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices and International Pharmaceuticals......8
Table 4: Endo International Plc’s (Pharmaceutical Product) Sales by Product Segment Worldwide (2013-2014) in Percentage for U.S. Branded Pharmaceuticals (Lidoderm, Opana, Voltaren, Percocet and Other Brands) and U.S. Generic Pharmaceuticals (Pain and Controlled Substances, Other Solid Doses and Other Liquids and Semi-Solids)......9
Table 5: Endo International Plc’s (Devices) Sales by Geographic Region Worldwide (2013-2014) in Percentage for United States and International......10
Pharmaceuticals......12
Table 6: Pharma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Injectables, Oral Solids, Tropicals and Others......12
Table 7: Pharmaceutical Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for China, Japan, USA and Others......13
Table 8: Pharmaceuticals Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia, Africa, and Australasia, European Union, Japan, Latin America, and North America......14
Table 9: Pharmaceuticals Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Generic, Originator Brand, and Others......15
Table 10: Pharmaceuticals Sales by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for Active Pharmaceutical Ingredients, Contrast Products, Radiopharmaceuticals, and Specialty Pharmaceuticals......16
Table 11: Pharmaceuticals Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biologics and Chemical Synthetic and Others......17
Table 12: New Pharmaceutical Licensed Drugs Market by Indication Worldwide (2015) - Percentage Share Breakdown by Value Sales for AIDS, Diabetes, Diabetes (DPP4), Hepatitis B, Hypertension, and Others......18
Table 13: New Pharmaceutical Licensed Drugs Market by Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Humulin, Trajenta, Truvada, Twynsta, Viread, and Others......19
Table 14: Emerging Market Pharma Sales by Country Worldwide (2015) - Percentage Share Breakdown by Value Sales for Africa & Middle East, Brazil, China, India, Russia, and Others......20
Table 15: Research & Development Spending in Pharmaceuticals by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for Approval, Discovery, Pre-Clinical, Phase I, Phase II, Phase III, Phase IV, and Others......21
Table 16: Pharmaceutical Consumption by Category in Australia (2015) - Percentage Share Breakdown for Aged over 65 Years, and Aged under 65 Years......22
Table 17: Pharmaceutical Market by Region in Brazil (2015) - Percentage Share Breakdown by Value Sales for Mid-West, North, Northeast, São Paulo, South, and Others......23
Table 18: Pharmaceutical Sales by Category in Brazil (2015) - Percentage Share Breakdown by Value for Generics, Over the Counter (OTC) Drugs, and Prescription......24
Table 19: Pharmaceutical Market by Category in Canada (2015) - Percentage Share Breakdown by Value for Hospital and Retail......25
Table 20: Pharmaceutical Distribution Market by Region in China (2015) – Percentage Share Breakdown by Value for Eastern China, North East China, Northern China, Northwestern China, Southern China, and Southwestern China......26
Table 21: Pharmaceuticals Market by Therapeutic Area in China (2015) - Percentage Share Breakdown by Value Sales for Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular Diseases, Musculo-Skeletal System, Nervous System, Oncology, Respiratory System, Systemic Anti-Infective, and Others......27
Table 22: Pharmaceutical Market by Country in Europe (2015) - Percentage Share Breakdown by Value Sales for France, Germany, Greece, Italy, Spain, UK, and Others......28
Table 23: Pharmaceutical Drugs Market by Category in Germany (2015) - Percentage Share Breakdown by Value Sales for Biopharmaceuticals, Pharma Drugs for Human Use, and Others......29
Table 24: Pharma Market by Category in Indonesia (2015) - Percentage Share Breakdown by Value for Branded Generics and Licensed, Over the Counter and Unbranded Generics......30
Table 25: Pharmaceutical Market by Region in Latin America (2015) - Percentage Share Breakdown by Value for Argentina, Brazil, Mexico, Venezuela and Others......31
Table 26: Retail Pharmaceutical Market by Type in Mexico (2015) - Percentage Share Breakdown by Value for Private Market and Public Market......32
Table 27: Spending on Pharmaceutical by Category in Nigeria (2015) - Percentage Share Breakdown by Value for Generic Drug Sales, Over-The-Counter Medicine Sales and Patented Drug Sales......33
Table 28: Private Pharmaceuticals Market by Segment in South Africa (2015) - Percentage Share Breakdown by Value for Branded and Ethical, Generic, Over the Counter and Others......34
Table 29: Pharmaceutical Drugs Manufacturers by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Biological Products, Medicinal and Botanical Products, Oncological Products, and Others......35
Table 30: Speciality Pharmaceuticals Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Anti-Coagulant, Growth Hormone, Hepatitis C, HIV/AIDS (incl oral solids), IVIG/Hemophilia, Macular Degeneration, Multiple Sclerosis, Oncology (incl. oral solids), Pulmonary Arterial Hypertension, Renal, Rheumatoid arthritis/Chrohn's, Transplant, and Others......36
Table 31: Pharmaceutical Market by Category in Vietnam (2015) - Percentage Share Breakdown by Value for Generic Drugs, Patented Drugs and Others......37
Urology Market......38
Table 32: Urology Market by Product Segment Worldwide (2015) - Percentage Breakdown by Value for Basic Drainage, Catheter Stabilization, Continence, Temperature Management, and Urological Specialties......38
Table 33: Urology Care Market by Region Worldwide (2015) - Percentage Share Breakdown for Europe, North America, and Rest of World (RoW)......39
Table 34: Urology Market by Category in North America and Europe (2015) - Percentage Share Breakdown by Value for Erectile Dysfunction, Gynaecological Pain, Hypogonadism, Interstitial Cystitis/Painful Bladder Syndrome, Premature Ejaculation, Urinary Incontinence, and Urological Cancers......40
Table 35: Urology and Gynaecology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Dialysis Equipment, Gynaecology Devices, Urinary Catheters, and Urology Devices......41
Ostomy Care......42
Table 36: Ostomy Care Market by Region Worldwide (2015) - Percentage Share Breakdown for Europe, North America, and Rest Of World (RoW)......42
Continence Care......43
Table 37: Continence Care Market by Region Worldwide (2015) - Percentage Share Breakdown for Europe, North America, and Rest of World (RoW)......43
Table 38: Incontinence Pads Market by Product Category in Australia (2015) - Percentage Share Breakdown by Value for Poise, Tena, and Others......44
Table 39: Incontinence Products Market by Region in the US (2015) - Percentage Share Breakdown by Value for Asia, Eastern Europe, Latin America, North America, Western Europe, and Others......45
Urinary Incontinence......46
Table 40: Urinary Continence Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Americas, Europe, and Rest of World......46
Table 41: Prevalence of Urinary Incontinence by Gender in the US (2015) - Percentage Share Breakdown for Men and Women......47
Table 42: Prevalence of Urinary Incontinence in Women (Age Group (>60)) by Type in the US (2015) - Percentage Share Breakdown for Did Not Experience, and Experience......48
Table 43: Prevalence of Urinary Incontinence in Women (Age Group (18-44)) by Type in the US (2015) - Percentage Share Breakdown for Did Not Experience, and Experience......49
Overactive Bladder (OAB)......50
Table 44: Prevalence of Overactive Bladder (OAB) in Men (Age >18) by Type in the US (2015) - Percentage Market Share Breakdown for Did Not Experience, and Experience......50
Table 45: Prevalence of Overactive Bladder (OAB) in Women (Age >18) by Type in the US (2015) - Percentage Market Share Breakdown for Did Not Experience, and Experience......51
Urinary Incontinence Drugs......52
Table 46: Urinary Incontinence Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anticholinergic Agents, and Newer Therapies......52
Table 47: Urinary Incontinence Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Detrol, Detrol LA (PFE), Newer Therapies (ACT, AGN, PFE), Oxybutinin, and Others (Generics)......53
Generic Drugs......54
Table 48: Generics Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, India, North America, Russia and Other CIS and Rest of the World......54
Table 49: Generic Pharmaceuticals Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Diabetes, Hormonal Drugs, Oncology, Respiratory, Rheumatology, and Others......55
Over the Counter (OTC) Drugs......56
Table 50: OTC Market (Private Label and Others) by Region Worldwide (2015) - Percentage Share Breakdown by Values Sales for Australia, Canada, Chile, France, Germany, Israel, Japan, Netherlands, Russia, United Kingdom, USA and Rest of the World......56
Table 51: OTC Drug Sales by Category in China (2015) - Percentage Market Share Breakdown by Value for Anti-Inflammatory, Cold, Gastrointestinal, Gynecological, Minerals, Tonics, Vitamins, Supplements, and Others......57
Table 52: OTC Drugs Market by Channel in China (2015) - Percentage Share Breakdown by Value Sales for Clinics, Community Hospital, General Hospital, Pharmacy, Supermarket, and Others......58
Table 53: Over - The - Counter (OTC) Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for Cough, Cold, Allergy & Sinus, Digestives, Pain Relief, Vitamins & Supplements, Weight Loss & Nutritional Meal Replacements and Others......59
Ophthalmic Drugs......60
Table 54: Ophthalmic Antibiotic Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Besivance, Moxeza, Vigamox, Zymaxid and Generic & Others......60
Table 55: Ophthalmic Steroid Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Alrex, Durezol, Lotemax, Ozurdex and Generic & Others......61
Testosterone......62
Table 56: Testosterone Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Gel, Injection (Long Acting), Injection (Short Acting), Oral, and Patch......62
Table 57: Testosterone Market by Product in the US (2015) - Percentage Share Breakdown by Value for Androderm, Androgel, Axiron, Depo-Testosterone, Fortesta, Testim, Testosterone Cypionate, Testosterone Enanthate, and Others......63
Table 58: Testosterone Market by Type in the US (2015) - Percentage Share Breakdown by Value for Gel, Injection (Long Acting), Injection (Short Acting), Oral, and Patch......64
Testosterone Replacement Therapy......65
Table 59: Testosterone Replacement Therapy Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for ANDROGEL, AXIRON, INJECTABLES, TESTIM and Others......65
Table 60: Testosterone Replacement Therapy Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Injectables and Topicals......66
Table 61: Topical Testosterone Treatment Therapy Market by Product in the US (2015) - Percentage Share Breakdown by Volume for Androgel, Axiron and Other......67
Table 62: Testosterone Replacement Therapy (TRT) Market by Type in the UK (2015) - Percentage Share Breakdown by Value for Capsules, Gels, Injections, and Patches......68
Testosterone Gel and Patch Products......69
Table 63: Testosterone Gel and Patch Market by Product in the US (2015) - Percentage Share Breakdown by Value for Androderm 2.5mg, Androderm 5mg, Androgel 12.5mg, Androgel 20.25mg, Androgel 25mg, Androgel 50mg, Axiron 30mg and 1.5ml, Fortesta 10mg, and Testim 50mg......69
Pharmaceuticals......70
Table 64: Market Shares of Leading Pharmaceutical Companies in Australia (2015) - Percentage Share Breakdown by Value for AstraZeneca, Pfizer, Inc. and Others......70
Table 65: Market Shares of Leading Pharmaceutical Distributors in Brazil (2015) - Percentage Share Breakdown by Value for Panpharma Participacoes S.A., Profarma Distribuidora de Produtos Farmaceuticos S.A., Santa Cruz and Others......71
Table 66: Market Shares of Leading Pharmaceutical Companies in Indonesia (2015) - Percentage Breakdown by Value Sales for Dexa Medica Group, PT Kalbe Farma Tbk., Pfizer Indonesia PT Tbk, Sanbe Farma PT, and Others......72
Table 67: Market Shares of Leading Pharmaceutical Suppliers to Hospitals in Indonesia (2015) - Percentage Breakdown by Value Sales for Dexa Medica Group, PT Kalbe Farma, Tbk, Sanbe Farma PT, Soho Group, and Others......73
Table 68: Market Shares of Leading Pharmaceutical Drugs Manufacturers in the US (2015) - Percentage Breakdown by Value for Amgen, Eli Lilly and Co., Johnson and Johnson Co, Merck & Co., Inc., Pfizer, Inc., and Others......74
Table 69: Market Shares of Leading Pharmaceutical Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Abbott Laboratories, Amgen Corporation, AstraZeneca Plc, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......75
Pain Management Drugs......76
Table 70: Market Shares of Leading Pain Management Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Endo International Plc, Johnson & Johnson, Pfizer, Inc., and Others......76
Table 71: Market Shares of Leading Pain Remedies Manufacturers for Over-the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for Bayer HealthCare AG, Johnson & Johnson Private Limited, Pfizer, Inc., Prestige Brands Holdings, Inc., Private-label and Others......77
Table 72: Market Shares of Leading Pain Remedy Producers Sales in the US OTC Market (2014) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson, Novartis AG, Pfizer, Inc., Prestige Brands Holdings, Inc., Private Label and Others......78
Table 73: Market Shares of Leading Oral Pain Relief Brands through Food Store in the US (2015) - Percentage Share Breakdown by Value for Anbesol, Baby Orajel, Kank A, Kank A Softbrush, Orajel, Private Label, and Others......79
Table 74: Market Shares of Leading Oral Pain Relief Brands through Supermarkets, Drugstores, Mass Merchandisers (including Wal-Mart), Gas & Convenience Stores, Military Commissaries, and Select Club and Dollar Retail Chains in the US (2015) - Percentage Share Breakdown by Value for Anbesol, BabyOrajel, Hyland's, KankA, Orajel, and Others......80
Table 75: Market Shares of Leading Oral Pain Remedy Brands by Value Sales through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Share Breakdown for Anbesol, Baby Orajel, Glyoxide, Kank-A, Orajel, Private Label, and Others......81
Urinary Incontinence Therapeutics......82
Table 76: Market Shares of Leading Urinary Incontinence Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Eli Lilly and Company, Johnson & Johnson, Novartis AG, Pfizer, Inc., and Others......82
Generic Pharmaceuticals......83
Table 77: Global IV Generics Drug Market by Value Sales (2015) - Percentage Share Breakdown for Fresenius Kabi AG, Hospira, Inc., Mylan, Inc., Novartis International AG, Teva Pharmaceutical Industries Ltd., and Others......83
Table 78: Market Shares of Leading Generic Injectable Drug Manufacturers Worldwide (2015) - Percentage Breakdown by Volume for Baxter International, Inc., Fresenius SE & Co. KGaA, Hikma Pharmaceuticals Plc, Hospira, Inc., Novartis AG, Pfizer, Inc., Sagent Pharmaceuticals, Inc., Sanofi S.A., and Other......84
Table 79: Market Shares of Leading Generics Manufacturers in Australia (2015) - Percentage Share Breakdown by Value for Apotex, Inc., Aspen Pharmaceutical Holdings Ltd., Mylan, Inc., Sandoz and Others......85
Table 80: Market Shares of Leading Generics Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Ems Sigma Pharma Group, Eurofarma Laboratórios, Hypermarcas S.A., Pfizer, Inc., Sanofi - Medley Indústria Farmacêutica Ltda and Others......86
Table 81: Market Shares of Leading Branded Generic Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Cimed Indústria Farmacêutica Ltda, Ems Sigma Pharma Group, Hypermarcas S.A., Pfizer, Inc., Takeda Pharmaceutical Company Limited, União Química Farmacêutica Nacional S.A and Others......87
Table 82: Market Shares of Leading Generic Pharmaceutical Companies by Value Sales in India (2014) - Percentage Breakdown for Abbott India Ltd., Alkem Laboratories Ltd., Cipla Ltd., GlaxoSmithKline Pharmaceuticals Ltd. (GSK), Lupin Ltd., Mankind Pharma, Pfizer Ltd., Ranbaxy Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Zydus Cadila and Others......88
Table 83: Market Shares of Leading Generics Manufacturers by Value Sales in South Africa (2014) - Percentage Breakdown for Adcock Ingram, Aspen Pharmacare Holdings Limited, Cipla Global Limited, Lupin Limited, Novartis International AG, Sanofi S.A., and Others......89
Table 84: Market Shares of Leading Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Volume for Actavis plc, Mylan N.V., Sandoz, Teva Pharmaceutical Industries Ltd. and Others......90
Table 85: Market Shares of Leading Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Apotex, Inc., Dr. Reddy’s Laboratories Ltd. and GlaxoSmithKline......91
Table 86: Market Shares of Leading Derma Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Actavis plc, Perrigo Company plc, Sandoz, Taro Pharmaceutical Industries Ltd. and Others......92
Table 87: Market Shares of Leading Non-Branded Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Actavis, Mylan N.V., Teva Pharmaceutical Industries Ltd. and Others......93
Table 88: Market Shares of Leading Generic Injectable Drug Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Baxter International, Inc., Fresenius, Hospira, Inc., Novartis (Sandoz), and Others......94
IV Generic Drugs......95
Table 89: Market Shares of Leading IV Generic Drugs Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Baxter International, Inc., Fresenius Kabi AG, Hospira, Inc., Novartis International AG, Sun Pharmaceutical Industries Limited and Others......95
Generic Lidoderm......96
Table 90: Market Shares of Leading Generic Lidoderm Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Actavis plc, Endo International plc authorized Generic, Mylan N.V., and Other Generics......96
Generic Percocet......97
Table 91: Market Shares of Leading Generic Percocet Manufacturers in the US (2015) - Percentage Breakdown by Value for Actavis Plc, Mallinckrodt Pharmaceuticals, and Others......97
Generic Vicodin......98
Table 92: Market Shares of Leading Generic Vicodin Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Actavis Plc, Mallinckrodt, and Others......98
Over the Counter (OTC) Drugs......99
Table 93: Market Shares of Leading Over the Counter Drugs Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline-Novartis International AG, Johnson & Johnson and Others......99
Table 94: Market Shares of Leading Over the Counter (OTC) Drugs Manufacturers in Brazil (2015) - Percentage Share Breakdown by Value for Abbott Laboratories, GlaxoSmithKline, Johnson & Johnson, Sanofi-Aventis and Others......100
Table 95: Market Shares of Leading Over The Counter (OTC) Drugs Manufacturers in Indonesia (2015) - Percentage Share Breakdown by Value for PT Kalbe Farma and Others......101
Injectable Drugs......102
Table 96: Market Shares of Leading Injectable Drug Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co. KGaA, Hospira, Inc., Novartis AG, Pfizer, Inc., West-Ward Pharmaceuticals Corporation, and Others......102
Table 97: Market Shares of Leading Generic Injectable Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Fresenius SE & Co., Hikma Pharmaceuticals, Hospira, Inc., Luitpold Pharmaceuticals, Inc. and Others......103
Table 98: Market Shares of Leading Injectable Manufacturers by Value Sales in France (2014) - Percentage Breakdown for Aguettant Limited, Baxter International, Inc., B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., Lake Forest Park Medical Clinic (LFP), Mylan Laboratories, Inc., Novartis International AG (Sandoz), Laboratoires PANPHARMA S.A., Sanofi S.A., and Others......104
Table 99: Market Shares of Leading Injectable Manufacturers by Value Sales in Germany (2014) - Percentage Breakdown for AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Medac GmbH, Novartis International AG (Sandoz), Sanofi S.A.,Teva Pharmaceutical Industries Ltd. and Others......105
Table 100: Market Shares of Leading Injectable Manufacturers by Value Sales in Italy (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Hospira, Inc., Johnson & Johnson, KEDRION GROUP S.p.A., Novartis International AG (Sandoz), Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd. and Others......106
Table 101: Market Shares of Leading Injectable Manufacturers by Value Sales in Spain (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Ges Genericos Españoles Laboratorio S.A., Grifols, S.A, Hospira, Inc., Johnson & Johnson, Normon S.A., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......107
Table 102: Market Shares of Leading Injectable Manufacturers by Value Sales in the UK (2014) - Percentage Breakdown for Actavis Plc (Watson), AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Hospira, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......108
Table 103: Market Shares of Leading Injectable Miotics Manufacturers in the US (2015) - Percentage Breakdown by Value for Alcon Incorporated, and Novartis International AG......109
Therapeutic Providers......110
Table 104: Market Shares of Leading Therapeutic Providers (Alzheimer's Disease, Bone Diseases, Cardiology, CNS, Dermatology, Diabetes/Metabolic, Epilepsy, G.I./Ulcer, HBV/HCV, Infectious Disease, Multiple Sclerosis, Obesity, Onc./Hematology, Ophthalmology, Orphan Disease, Pain Management, Respiratory, Rheumatology, Sleep Disorders, Urinary Incont., and Women's Health) by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Biogen Idec, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Endo International Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......110
Table 105: Endo Pharmaceuticals, Inc.’s Sales by Product Segment Worldwide (2013) in Percentage for Lidoderm®, Opana® ER, Voltaren® Gel, Percocet®, Frova®, Fortesta® Gel and Supprelin® LA, Other Brands, Qualitest and AMS (American Medical Systems)......111
Table 106: Endo Pharmaceuticals, Inc.’s Revenue by Category Worldwide (2013) in Percentage for Pharmaceutical Product, Devices and Others......112